Aarti Drugs Limited — Call Transcript 2021

Oct 23, 2021

==> picture [477 x 82] intentionally omitted <==

Ref: ADL/SE/2021-22 October 23, 2021

To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Phiroze Jeejeebhoy Towers Limited Dalal Street, “Exchange Plaza”, Plot No C/1, Mumbai 400 001 G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400 051 BSE CODE: 524348 NSE CODE: AARTIDRUGS

Dear Sir/Madam,

Ref: Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Conference Call for the Investors and Analysts has been scheduled on Thursday, October 28, 2021 at 3:00 PM IST to discuss the Company’s financial performance for the Quarter and half year ended September 30, 2021. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

==> picture [88 x 36] intentionally omitted <==

RUSHIKESH DEOLE

==> picture [123 x 89] intentionally omitted <==

COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 32] intentionally omitted <==

==> picture [117 x 54] intentionally omitted <==

Aarti Drugs Limited

Cordially invites you to

Conference Call

To discuss the financial performance for the Quarter and Half-year ended 30[th] September, 2021

Day/Date : Thursday, 28[th] October, 2021 Time : 3:00 PM, IST

Diamond Pass : Please Click here to express join the Call

Primary Number:	+91 226280 1309
	+91 22 7115 8210
Toll Free Number:	Hongkong– 800964448
	Singapore– 8001012045
	UK– 08081011573
	US– 18667462133

Participants:

Mr. Harshit Savla – Jt. Managing Director Mr. Harit Shah – Wholetime Director

Mr. Adhish Patil – Chief Finance Officer

Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited

We look forward to your participation

RSVP

Jigar Kavaiya / Chinmay Madgulkar, Strategic Growth Advisors Pvt. Ltd., Contact: +91 99206 02034/ 98600 88296